Literature DB >> 25112857

Prostate cancer: Is active surveillance safe for obese patients?

Stephen Freedland1, Lorelei Mucci2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25112857     DOI： 10.1038/nrurol.2014.207

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.

Authors:  Bimal Bhindi; Girish S Kulkarni; Antonio Finelli; Shabbir M H Alibhai; Robert J Hamilton; Ants Toi; Theodorus H van der Kwast; Andrew Evans; Karen Hersey; Michael A S Jewett; Alexandre R Zlotta; John Trachtenberg; Neil E Fleshner
Journal:  Eur Urol       Date:  2014-06-18       Impact factor: 20.096

2.  Obesity and long-term survival after radical prostatectomy.

Authors:  Heather J Chalfin; Seung Bae Lee; Byong Chang Jeong; Stephen J Freedland; Hamid Alai; Zhaoyong Feng; Bruce J Trock; Alan W Partin; Elizabeth Humphreys; Patrick C Walsh; Misop Han
Journal:  J Urol       Date:  2014-04-21       Impact factor: 7.450

Review 3.  Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.

Authors:  Yin Cao; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-13

4.  Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression.

Authors:  P Mukherjee; A V Sotnikov; H J Mangian; J R Zhou; W J Visek; S K Clinton
Journal:  J Natl Cancer Inst       Date:  1999-03-17       Impact factor: 13.506

5.  Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.

Authors:  Corinne E Joshu; Alison M Mondul; Andy Menke; Cari Meinhold; Misop Han; Elizabeth B Humphreys; Stephen J Freedland; Patrick C Walsh; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2011-02-16

6.  Risk of urinary incontinence following prostatectomy: the role of physical activity and obesity.

Authors:  Kathleen Y Wolin; Jason Luly; Siobhan Sutcliffe; Gerald L Andriole; Adam S Kibel
Journal:  J Urol       Date:  2009-12-16       Impact factor: 7.450

Review 7.  Obesity and prostate cancer: weighing the evidence.

Authors:  Emma H Allott; Elizabeth M Masko; Stephen J Freedland
Journal:  Eur Urol       Date:  2012-11-15       Impact factor: 20.096

8.  Temporal trends in cause of death among Swedish and US men with prostate cancer.

Authors:  Mara M Epstein; Gustaf Edgren; Jennifer R Rider; Lorelei A Mucci; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2012-07-25       Impact factor: 13.506

9.  Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.

Authors:  Tammy Ho; Leah Gerber; William J Aronson; Martha K Terris; Joseph C Presti; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Eur Urol       Date:  2012-08-20       Impact factor: 20.096

10.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.

Authors:  Jing Ma; Haojie Li; Ed Giovannucci; Lorelei Mucci; Weiliang Qiu; Paul L Nguyen; J Michael Gaziano; Michael Pollak; Meir J Stampfer
Journal:  Lancet Oncol       Date:  2008-10-03       Impact factor: 41.316
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.